Skip to content

Circles

E

Endovia Health Sciences, Inc.

EDVA· NYSE

E

EDVAEndovia Health Sciences, Inc.

EDVAEndovia Health Sciences, Inc.·Earnings record

Q2 2012

Source filing unavailable

Previous · Q1 2012 Next · Q3 2012

Q2 2012 · —

Revenue

$79.22K

no prior Q2 2011 on file

Net Income

$7.64K

no prior Q2 2011 on file

EPS Diluted

$0.00

no prior Q2 2011 on file

Gross Profit$43,565—

Operating Income$8,479—

Operating Cash Flowderived

Same quarter

no prior Q2 2011 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Filing lag

Quarterly history

Q1 ’12Q2 ’12Q3 ’12 Q4 ’12^d Q1 ’13 Q2 ’13 Q3 ’13 Q4 ’13^d Q1 ’14…

Endovia Health Sciences, Inc. · CIK 1553788 · Engraved from SEC EDGAR

$4,111

—

Margins · derived

Gross margin55.0%

Operating margin10.7%

Net margin9.6%

Thaler ResearchEngraved from SEC EDGAR© 2026 Thaler. All rights reserved.Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Platform

Using AI API SDKs CLI

Research

News Listen Earnings Insiders Holders Compare Metrics

Screener Watchlists Pies Notes Your companies

Learn

Thaler

Thaler Agent Promise Provenance Circles Account Terms Privacy